1. Home
  2. NE vs AMRX Comparison

NE vs AMRX Comparison

Compare NE & AMRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Noble Corporation plc A

NE

Noble Corporation plc A

HOLD

Current Price

$45.82

Market Cap

4.7B

ML Signal

HOLD

Logo Amneal Pharmaceuticals Inc.

AMRX

Amneal Pharmaceuticals Inc.

HOLD

Current Price

$14.82

Market Cap

4.0B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
NE
AMRX
Founded
1985
2002
Country
United States
United States
Employees
N/A
N/A
Industry
Other Specialty Stores
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
4.7B
4.0B
IPO Year
N/A
N/A

Fundamental Metrics

Financial Performance
Metric
NE
AMRX
Price
$45.82
$14.82
Analyst Decision
Buy
Buy
Analyst Count
7
4
Target Price
$37.57
$13.25
AVG Volume (30 Days)
2.6M
3.8M
Earning Date
02-11-2026
02-27-2026
Dividend Yield
4.36%
N/A
EPS Growth
N/A
N/A
EPS
1.35
0.02
Revenue
$3,107,207,000.00
$2,934,959,000.00
Revenue This Year
N/A
$9.99
Revenue Next Year
$7.99
$6.48
P/E Ratio
$33.94
$789.64
Revenue Growth
6.46
9.50
52 Week Low
$17.40
$6.69
52 Week High
$46.31
$15.00

Technical Indicators

Market Signals
Indicator
NE
AMRX
Relative Strength Index (RSI) 79.05 68.93
Support Level $40.69 $14.55
Resistance Level $44.17 $14.99
Average True Range (ATR) 1.95 0.50
MACD 0.78 0.02
Stochastic Oscillator 96.02 87.71

Price Performance

Historical Comparison
NE
AMRX

About NE Noble Corporation plc A

Noble Corp PLC is an offshore drilling contractor for the oil and gas industry that provides contract drilling services to the international oil and gas industry with its fleet of mobile offshore drilling units. The company focuses on a high-specification fleet of floating and jackup rigs and the deployment of its drilling rigs in oil and gas basins around the world.

About AMRX Amneal Pharmaceuticals Inc.

Amneal Pharmaceuticals Inc is a pharmaceutical company operating in the U.S., India, and Ireland. With three reportable segments; Affordable Medicines, Specialty, and AvKARE - It develops, manufactures, and distributes a diverse portfolio of essential medicines. The Affordable Medicines segment focuses on a wide range of dosage forms and delivery systems, contributing significantly to revenues. The Specialty segment promotes proprietary branded pharmaceuticals, particularly targeting the central nervous system and endocrine disorders. The AvKARE segment provides pharmaceuticals and medical products to governmental agencies, specializing in re-packaging and wholesale distribution, with a focus on offering consistent care and pricing to qualified entities.

Share on Social Networks: